Adma Biologics, Inc.

ADMA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001368514

SEC filings (opens in a new tab)

No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.

Q3 2023 vs. Q2 2023

How the institutions holding Adma Biologics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ADMA: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	179	1	188	+10
Shares	165.5M	14.7K	171.2M	+5.67M (+3.4%)
Value	$610.6M	$54.2K	$612.7M	+$2.16M (+0.4%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Adma Biologics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ADMA in Q3 2023
Institution	Shares	Value	% of portfolio
Walleye Capital LLC	926,745	$3.32M	0.05%
EAM Global Investors LLC	632,352	$2.26M	0.61%
Marshall Wace, LLP	143,479	$513.7K	0.00%
Campbell & CO Investment Adviser LLC	120,297	$430.7K	0.05%
Bayesian Capital Management, LP	76,100	$272.4K	0.03%
Aigen Investment Management, LP	39,052	$139.8K	0.03%
Sherbrooke Park Advisers LLC	37,944	$135.8K	0.04%
Walleye Trading LLC	30,776	$110.2K	0.00%
HSBC Holdings PLC	26,109	$94.3K	0.00%
CIBC Private Wealth Group, LLC	22,990	$82.3K	0.00%
Algert Global LLC	22,420	$80.3K	0.00%
Nebula Research & Development LLC	22,326	$79.9K	0.04%
SG Americas Securities, LLC	18,023	$65.0K	0.00%
DekaBank Deutsche Girozentrale	16,178	$58.0K	0.00%
Sawgrass Asset Management LLC	15,405	$55.1K	0.01%
Pictet Asset Management Holding SA	14,696	$52.6K	0.00%
Intrust Bank NA	14,229	$50.9K	0.01%
Arkadios Wealth Advisors	11,260	$40.3K	0.00%
GTS Securities LLC	10,571	$37.8K	0.00%
CIBC World Markets Inc.	10,467	$37.0K	0.00%
Stephens Consulting, LLC	10,000	$35.8K	0.01%
Simplex Trading, LLC	1,693	$6.00K	0.00%
Oliver Lagore Vanvalin Investment Group	1,300	$4.65K	0.00%
IFP Advisors, Inc	1,150	$4.12K	0.00%
Aspire Private Capital, LLC	200	$716	0.00%

Sold out (15)

Institutions that held Adma Biologics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ADMA in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Verition Fund Management LLC	707,028	$2.61M
Occudo Quantitative Strategies LP	141,556	$522.3K
Caxton Associates LP	140,190	$517.3K
Schonfeld Strategic Advisors LLC	28,835	$106.4K
Bailard, Inc.	27,030	$99.7K
Virtu Financial LLC	24,684	$91.0K
Creative Planning	22,735	$83.9K
Ergoteles LLC	19,462	$71.8K
Y-Intercept (Hong Kong) Ltd	19,204	$70.9K
Susquehanna Fundamental Investments, LLC	13,310	$49.1K
Tucker Asset Management LLC	11,599	$42.8K
Robeco Institutional Asset Management B.V.	10,938	$40.4K
Impact Partnership Wealth, LLC	424	$1.56K
NewSquare Capital LLC	200	$738
Coppell Advisory Solutions LLC	365	–

Not filed for Q3 2023 yet (1)

Institutions that held Adma Biologics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADMA in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Pictet Asset Management SA	14,696	$54.2K